Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

This guideline summary is intended to guide the diagnosis, management, and treatment of adults with hepatitis C virus (HCV). The guideline focuses on universal screening, management of incomplete treatment adherence, expanded eligibility for simplified chronic HCV treatment, updated treatment and retreatment recommendations, and management and treatment recommendations in the setting of transplantation. The panel consisted of members from the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA). 

Download PDF Version